Catherine Alexis Sims

Hormone Therapy Boxed Warning Removal May Expand Its Use in Rheumatic Disease Care

Dr. Catherine Sims Leads Team Researching Pregnancy and Vasculitis

Treat-to-Target Approach for RA Improves Time to Pregnancy

US Supreme Court decision on mifepristone ‘not a victory, but a punt’

OTC birth control debut in 2024 ‘empowers’ patients with rheumatic diseases

Catherine Sims, ACR 2022: Azathioprine metabolite levels throughout pregnancy in women with rheumatic disease